Administration of antenatal glucocorticoids prevents pulmonary artery structural changes in nitrofen-induced congenital diaphragmatic hernia in rats

Journal of Pediatric Surgery

Volumn 33, Issue 7, 1998, Pages 1052-1056

  Taira, Yasuhiko ^a   Miyazaki, Eiji ^a   Ohshiro, Kiyohiko ^a   Yamataka, Tamiki ^a   Puri, Prem ^a  

^a OUR LADY S CHILDREN S HOSPITAL   (Ireland)

Author keywords

Antenatal therapy; Congenital diaphragmatic hernia; Glucocorticoids; Pulmonary hypertension

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID; NITROFEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; CONGENITAL DIAPHRAGM HERNIA; CONTROLLED STUDY; DRUG EFFECT; DRUG INDUCED DISEASE; FETUS LUNG MATURATION; FUNCTIONAL RESIDUAL CAPACITY; LAMB; LUNG COMPLIANCE; LUNG VASCULAR RESISTANCE; NONHUMAN; PRENATAL PERIOD; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY HYPERTENSION; RAT;

EID: 0031843508     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3468(98)90530-9     Document Type: Conference Paper

References (28)

1. Puri P: Congenital diaphragmatic hernia. Curr Prob Surg 10:785-856, 1994
2. Yamataka T, Puri P: Pulmonary artery structural changes in pulmonary hypertension complicating congenital diaphragmatic hernia. J Pediatr Surg 32:387-390, 1997
3. Yamataka T, Puri P: Active collagen synthesis by pulmonary arteries in pulmonary hypertension complicated by congenital diaphragmatic hernia. J Pediatr Surg 32:682-687, 1997
4. Taira Y, Yamataka T, Miyazaki E, et al: Adventitial changes in pulmonary vasculature in congenital diaphragmatic hernia complicated by pulmonary hypertension. J Pediatr Surg 33:382-387, 1998
5. Suen HC, Bloch KD, Donahoe PK: Antenatal glucocorticoid corrects pulmonary immaturity in experimentally induced congenital diaphragmatic hernia in rats. Pediatr Res 35:523-529, 1994
6. Suen HC, Losty P, Donahoe PK, et al: Combined antenatal thyrotropin-releasing hormone and low-dose glucocorticoid therapy improves the pulmonary biochemical immaturity in congenital diaphragmatic hernia. J Pediatr Surg 29:359-363, 1994
7. Losty PD, Suen HC, Manganaro TF, et al: Prenatal hormonal therapy improves pulmonary compliance in the nitrofen-induced CDH rat model. J Pediatr Surg 30:420-426, 1995
8. Chazova I, Loyd JE, Zhdanov SZ, et al: Pulmonary artery adventitial changes and venous involvement in primary pulmonary hypertension. Am J Pathol 146:389-397, 1995
9. Hosoda Y: Pathology of pulmonary hypertension: A human and experimental study. Pathol Int 44:241-267, 1994
10. Okoyc BO, Losty PD, Lloyd DA, et al: The effect of prenatal glucocorticoids on pulmonary vascular muscularisation in nitrofen induced congenital diaphragmatic hernia. Presented at the 44th Annual International Congress of the British Association of Pediatric Surgeons, Istanbul, July 1997
11. Jaskoll T, Choy HA, Melnick M: The glucocorticoid-glucocorticoid receptor signal transduction pathway, transforming growth factor-β, and embryonic mouse lung development in vivo. Pediatr Res 39:749-759, 1996
12. Ballard PL: Hormonal regulation of pulmonary surfactant. Endocr Rev 10:165-181, 1989
13. Caspi E, Schreyer P, Weinraub Z, et al: Prevention of the respiratory distress syndrome in premature infants by antepartum glucocorticoid therapy. Br J Obstet Gynaecol 83:187-193, 1976
14. Collaborative Group on Antenatal Steroid Therapy: Effects of antenatal dexamethasone administration in the infant: Long-term follow-up. J Pediatr 104:259-267, 1984
15. Asabe K, Hashimoto S, Suita S, et al: Maternal dexamethasone treatment enhances the expression of surfactant apoprotein A in the hypoplastic lung of rabbit fetuses induced by oligohydramnios. J Pediatr Surg 31:1369-1375, 1996
16. Wispe JR, Clark JC, Warner BB, et al: Tumor necrosis factor-alpha inhibits expression of pulmonary surfactant protein. J Clin Invest 86:1954-1960, 1990
17. Balibrea-Cantero JL, Arias-Diaz J, Garcia C, et al: Effect of pentoxifylline on the inhibition of surfactant synthesis induced by TNF-α in human type II pneumocytes. Am J Crit Care Med 149:699-706, 1994
18. Hertzog JH, Godinez MH, Godinez RI: Tumor necrosis factor-α alters phospholipid content in the bronchoalveolar lavage-accessible space of isolated perfused rats lungs. Crit Care Med 22:1969-1975, 1994
19. Jaskoll T, Boyer PD, Melnick M: Tumor necrosis factor-α and embryonic mouse lung morphogenesis. Developmental Dynamics 201: 137-150, 1994
20. Murch SH, MacDonald TT, Wood CBS, et al: Tumour necrosis factor in the bronchoalveolar secretions of infants with the respiratory distress syndrome and the effect of dexamethasone treatment. Thorax 47:44-47, 1992
21. Beutler B, Krochin N, Milsark IW, et al: Control of cachectin (tumour necrosis factor) synthesis: Mechanisms of endotoxin resistance. Science 232:977-980, 1986
22. Tracey KJ, Vlassara H, Cerami A: Cachectin/tumour necrosis factor. Lancet i:1122-1126, 1989
23. Sherry B, Cerami A: Cachectin/tumor necrosis factor exerts endocrine, paracrine and autocrine control of inflammatory responses. J Cell Biol 107:1269-1277, 1988
24. Gladstone IM, Ehrenkranz RA, Jacobs HC: Pulmonary function tests and fluid balance in neonates with chronic lung disease during dexamethasone treatment. Pediatrics 84:1072-1076, 1989
25. Cummings JJ, D'Eugenio DB, Gross SJ: A controlled trial of dexamethasone in infants at high risk for bronchopulmonary dysplasia. N Engl J Med 320:1505-1510, 1989
26. Dukarm RC, Steinhorn RH, Morin FC: The normal pulmonary vascular transition at birth. Clin Perinatol 23:711-726, 1996
27. Miyazaki E, Ohshiro K, Taira Y, et al: Altered insulin-like growth factor 1 mRNA expression in human hypoplastic lung in congenital diaphragmatic hernia. Presented at the Canadian Association of Pediatric Surgeons, Banff, Canada, October 1997
28. Ohshiro K, Miyazaki E, Taira Y, et al: Increased TNF-α mRNA expression in hypoplastic lung in patients with congenital diaphragmatic hernia. Presented at the Surgical Section of the American Academy of Pediatrics Meeting, New Orleans, October 1997